A citation-based method for searching scientific literature

Kurt D Christensen, Megan Bell, Carrie L B Zawatsky, Lauren N Galbraith, Robert C Green, Allison M Hutchinson, Leila Jamal, Jessica L LeBlanc, Jennifer R Leonhard, Michelle Moore, Lisa Mullineaux, Natasha Petry, Dylan M Platt, Sherin Shaaban, April Schultz, Bethany D Tucker, Joel Van Heukelom, Elizabeth Wheeler, Emilie S Zoltick, Catherine Hajek. Front Genet 2021
Times Cited: 8







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
W S Bush, D R Crosslin, A Owusu-Obeng, J Wallace, B Almoguera, M A Basford, S J Bielinski, D S Carrell, J J Connolly, D Crawford,[...]. Clin Pharmacol Ther 2016
102
25

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
Mary V Relling, Teri E Klein, Roseann S Gammal, Michelle Whirl-Carrillo, James M Hoffman, Kelly E Caudle. Clin Pharmacol Ther 2020
70
25

Implementation of wide-scale pharmacogenetic testing in primary care.
Natasha Petry, Jordan Baye, Aissa Aifaoui, Russell A Wilke, Roxana A Lupu, John Savageau, Britni Gapp, Amanda Massmann, Deidre Hahn, Catherine Hajek,[...]. Pharmacogenomics 2019
12
25

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
902
25

Population genetic screening efficiently identifies carriers of autosomal dominant diseases.
J J Grzymski, G Elhanan, J A Morales Rosado, E Smith, K A Schlauch, R Read, C Rowan, N Slotnick, S Dabe, W J Metcalf,[...]. Nat Med 2020
41
25

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C Hiemke, N Bergemann, H W Clement, A Conca, J Deckert, K Domschke, G Eckermann, K Egberts, M Gerlach, C Greiner,[...]. Pharmacopsychiatry 2018
366
12

Antidepressant pharmacogenetics in children and young adults: A systematic review.
Abdullah Al Maruf, Alexandra Greenslade, Paul D Arnold, Chad Bousman. J Affect Disord 2019
15
12

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.
Toshi A Furukawa, Andrea Cipriani, Philip J Cowen, Stefan Leucht, Matthias Egger, Georgia Salanti. Lancet Psychiatry 2019
89
12

Pharmacogenetics in Psychiatry: An Update on Clinical Usability.
Ron H N van Schaik, Daniel J Müller, Alessandro Serretti, Magnus Ingelman-Sundberg. Front Pharmacol 2020
21
12

Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.
R C Kessler, H M van Loo, K J Wardenaar, R M Bossarte, L A Brenner, D D Ebert, P de Jonge, A A Nierenberg, A J Rosellini, N A Sampson,[...]. Epidemiol Psychiatr Sci 2017
63
12

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Kelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, Jesse J Swen, Cyrine E Haidar, Teri E Klein, Roseann S Gammal, Mary V Relling, Stuart A Scott, Daniel L Hertz,[...]. Clin Transl Sci 2020
169
12




Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
Chiara Fabbri, Joseph Zohar, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2018
27
12


Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Chad A Bousman, Katarina Arandjelovic, Serafino G Mancuso, Harris A Eyre, Boadie W Dunlop. Pharmacogenomics 2019
77
12

Pharmacogenomics: Prescribing Precisely.
Dyson T Wake, Nadim Ilbawi, Henry Mark Dunnenberger, Peter J Hulick. Med Clin North Am 2019
14
12


Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients.
Marin M Jukić, Tore Haslemo, Espen Molden, Magnus Ingelman-Sundberg. Am J Psychiatry 2018
63
12

Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine.
Laura B Ramsey, Cynthia A Prows, Kejian Zhang, Shannon N Saldaña, Michael T Sorter, John P Pestian, Richard J Wenstrup, Alexander A Vinks, Tracy A Glauser. Clin Pharmacol Ther 2019
34
12

Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Chad A Bousman, Susanne A Bengesser, Katherine J Aitchison, Azmeraw T Amare, Harald Aschauer, Bernhard T Baune, Bahareh Behroozi Asl, Jeffrey R Bishop, Margit Burmeister, Boris Chaumette,[...]. Pharmacopsychiatry 2021
37
12

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.
Joel A Morales-Rosado, Kashish Goel, Lingxin Zhang, Axel Åkerblom, Saurabh Baheti, John L Black, Niclas Eriksson, Lars Wallentin, Stefan James, Robert F Storey,[...]. Cardiovasc Drugs Ther 2021
4
25

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.
Paul Geeleher, Zhenyu Zhang, Fan Wang, Robert F Gruener, Aritro Nath, Gladys Morrison, Steven Bhutra, Robert L Grossman, R Stephanie Huang. Genome Res 2017
51
12

Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type.
Ann M Moyer, Brian Dukek, Patti Duellman, Brittany Schneider, Laurie Wakefield, Jennifer M Skierka, Rajeswari Avula, Aditya V Bhagwate, Krishna R Kalari, Justin D Kreuter,[...]. Hum Immunol 2020
1
100

Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.
M P Goetz, A Kamal, M M Ames. Clin Pharmacol Ther 2008
123
12


Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).
Suzette J Bielinski, Jennifer L St Sauver, Janet E Olson, Nicholas B Larson, John L Black, Steven E Scherer, Matthew E Bernard, Eric Boerwinkle, Bijan J Borah, Pedro J Caraballo,[...]. Int J Epidemiol 2020
20
12

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
Larisa H Cavallari, Sara L Van Driest, Cynthia A Prows, Jeffrey R Bishop, Nita A Limdi, Victoria M Pratt, Laura B Ramsey, D Max Smith, Sony Tuteja, Benjamin Q Duong,[...]. Genet Med 2019
37
12

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.
Matthew P Goetz, James M Rae, Vera J Suman, Stephanie L Safgren, Matthew M Ames, Daniel W Visscher, Carol Reynolds, Fergus J Couch, Wilma L Lingle, David A Flockhart,[...]. J Clin Oncol 2005
565
12

Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research.
Youssef M Roman, Kajua Lor, Txia Xiong, Kathleen Culhane-Pera, Robert J Straka. Per Med 2021
3
33

Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups.
Moataz E Mohamed, David P Schladt, Weihua Guan, Baolin Wu, Jessica van Setten, Brendan J Keating, David Iklé, Rory P Remmel, Casey R Dorr, Roslyn B Mannon,[...]. Am J Transplant 2019
17
12


Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen.
Werner Schroth, Matthew P Goetz, Ute Hamann, Peter A Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J Suman, Matthew M Ames,[...]. JAMA 2009
375
12

Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype-Based Dosing Algorithms.
Boguang Sun, Ya-Feng Wen, Kathleen A Culhane-Pera, Muaj Lo, Txia Xiong, Koobmeej Lee, Kerui Peng, Bharat Thyagarajan, Jeffrey R Bishop, Heather Zierhut,[...]. Pharmacotherapy 2021
5
20

Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.
W S Oetting, D P Schladt, W Guan, M B Miller, R P Remmel, C Dorr, K Sanghavi, R B Mannon, B Herrera, A J Matas,[...]. Am J Transplant 2016
64
12

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
K Sanghavi, R C Brundage, M B Miller, D P Schladt, A K Israni, W Guan, W S Oetting, R B Mannon, R P Remmel, A J Matas,[...]. Pharmacogenomics J 2017
46
12

Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.
Martin R Johnson, Kangsheng Wang, Robert B Diasio. Clin Cancer Res 2002
104
12

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing.
Casey R Dorr, Baolin Wu, Rory P Remmel, Amutha Muthusamy, David P Schladt, Juan E Abrahante, Weihua Guan, Roslyn B Mannon, Arthur J Matas, William S Oetting,[...]. Pharmacogenomics J 2019
8
12

PharmVar GeneFocus: CYP2D6.
Charity Nofziger, Amy J Turner, Katrin Sangkuhl, Michelle Whirl-Carrillo, José A G Agúndez, John L Black, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips,[...]. Clin Pharmacol Ther 2020
72
12


Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.
W S Oetting, B Wu, D P Schladt, W Guan, R P Remmel, R B Mannon, A J Matas, A K Israni, P A Jacobson. Pharmacogenomics J 2018
26
12

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Ursula Amstutz, Linda M Henricks, Steven M Offer, Julia Barbarino, Jan H M Schellens, Jesse J Swen, Teri E Klein, Howard L McLeod, Kelly E Caudle, Robert B Diasio,[...]. Clin Pharmacol Ther 2018
213
12


Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
149
12

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
K E Caudle, C F Thorn, T E Klein, J J Swen, H L McLeod, R B Diasio, M Schwab. Clin Pharmacol Ther 2013
233
12

SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability.
Pablo Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García, Marcos Navares-Gómez, Gina Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos. J Pers Med 2021
4
25

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers.
Pablo Zubiaur, Miriam Saiz-Rodríguez, Dolores Ochoa, Carmen Belmonte, Manuel Román, Gina Mejía, Samuel Martín-Vilchez, Francisco Abad-Santos. Pharmacogenomics J 2020
7
14

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.
David L Thomas, Chloe L Thio, Maureen P Martin, Ying Qi, Dongliang Ge, Colm O'Huigin, Judith Kidd, Kenneth Kidd, Salim I Khakoo, Graeme Alexander,[...]. Nature 2009
12

Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
Christina L Aquilante, David P Kao, Katy E Trinkley, Chen-Tan Lin, Kristy R Crooks, Emily C Hearst, Steven J Hess, Elizabeth L Kudron, Yee Ming Lee, Ina Liko,[...]. Pharmacogenomics 2020
13
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.